Take an OSA Pill and Call Me in the Morning
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Gaisl T, Haile S, Thiel S, Osswald M, Kohler M
. Efficacy of pharmacotherapy for OSA in adults: A systematic review and network meta-analysis. Sleep Med Rev. 2019; 46:74-86.
DOI: 10.1016/j.smrv.2019.04.009.
View
2.
Sprung V, Kemp G, Wilding J, Adams V, Murphy K, Burgess M
. Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive.... BMJ Open. 2020; 10(7):e038856.
PMC: 7380950.
DOI: 10.1136/bmjopen-2020-038856.
View
3.
Tanriover C, Ucku D, Akyol M, Cevik E, Kanbay A, Sridhar V
. Potential Use of SGLT-2 Inhibitors in Obstructive Sleep Apnea: A new treatment on the horizon. Sleep Breath. 2022; 27(1):77-89.
DOI: 10.1007/s11325-022-02606-1.
View
4.
Edwards B, Eckert D, McSharry D, Sands S, Desai A, Kehlmann G
. Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2014; 190(11):1293-300.
PMC: 4315811.
DOI: 10.1164/rccm.201404-0718OC.
View
5.
Neeland I, Eliasson B, Kasai T, Marx N, Zinman B, Inzucchi S
. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care. 2020; 43(12):3007-3015.
PMC: 7770278.
DOI: 10.2337/dc20-1096.
View